XNCR Xencor Inc

Xencor Inc is engaged in the field of biotechnology. The United States-based firm develops drugs to combat severe diseases such as allergies and cancers.

$28.38  +1.01 (3.69%)
As of 07/01/2022 10:19:30 EST     IEX book   CBOE book

Security Information
Category1:  US Equity
Category2:  Common stocks
Category3:  Small cap
GICS sector:  Health Care
Industry:  Biotechnology
Index country:  USA
Country of incorporation:  USA
IPO date:  12/03/2013
Outstanding shares:  59,542,935
Average volume:  481,774
Market cap:   $1,619,567,832
Current dividend yield:  0.00%
All SEC filings:     SEC Edgar Online
Quarterly filings:   10-Q
Annual filings:      10-K
Sedol:      BGCYWN8
Valuation   (See tab for details)
PE ratio:   14.99
PB ratio:   2.14
PS ratio:   4.96
Return on equity:   14.25%
Net income %:   33.28%

2022 © Stock Market MBA, Inc. Terms of use | Privacy policy